Dr. Haddad received his medical degree from Saint Joseph University, French Faculty of Medicine, and served as intern and resident at St. Luke’s Roosevelt Hospital Center, New York, New York. He served a fellowship in hematology/oncology at Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland. Dr. Haddad is a member of several professional societies, including the American Society of Clinical Oncology, American Association for Cancer Research, Cancer and Leukemia Group B, and the American Society for Therapeutic Radiology and Oncology.

Dr. Haddad’s current research activity involves the use of intensive chemoradiotherapy regimens for patients with locally advanced head and neck cancer with particular attention to radioprotection. He is also involved in a large phase III study comparing sequential chemoradiotherapy to concomitant chemoradiotherapy: The Paradigm Trial. Other initiatives currently being developed include collaboration with the NCI/CTEP to develop a phase II study looking at the use of depsipeptide in head and neck cancer, as well as looking at new molecules in head and neck cancer treatment. Dr. Haddad lectures extensively on head and neck cancer, both on the regional, national, and international level.

The Head and Neck Oncology Program is one component of the Harvard Head and Neck Oncology Program, a Harvard-wide effort in head and neck cancer, and provides the clinical and research center for the treatment and study of head and neck cancer at the Dana-Farber Cancer Institute, The Harvard Medical School, the Brigham and Women’s Hospital, The Beth-Israel Deaconess Medical Center, and the Harvard School of Dental Medicine.

The Head and Neck Oncology Program provides excellent multi-disciplinary care for the patients as its first order of business, and coordinates an extensive clinical and laboratory based research effort. Over 500 new cases of head and neck cancer are seen each year and more then 100 patients participate in active clinical trials and many more contribute blood and tissue samples for the molecular epidemiology program and tissue bank.